Clinical audit examining the impact of benzalkonium chloride‐free anti‐glaucoma medications on patients with symptoms of ocular surface disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1442-9071|43|3|214-220

ISSN： 1442-6404

Source： CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol.43, Iss.3, 2015-04, pp. : 214-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and patient tolerability of preservative‐free latanoprost compared with preservative prostaglandin analogs in patients with ocular hypertension or glaucoma

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effects of antioxidants on ocular blood flow in patients with glaucoma

By  

ACTA OPHTHALMOLOGICA, Vol. 96, Iss. 2, 2018-03 ,pp. : e237-e241

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: the safety of herpes zoster vaccination for patients with inflammatory bowel disease being treated with anti‐TNF medications—authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 448-448

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: the safety of herpes zoster vaccination for patients with inflammatory bowel disease being treated with anti‐TNF medications

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 446-447

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mechanisms of benzalkonium chloride toxicity in a human trabecular meshwork cell line and the protective role of preservative‐free tafluprost

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 43, Iss. 2, 2015-03 ,pp. : 164-172

John Wiley & Sons Inc

Access to resources Recommend Favorite